RELATED ARTICLES
Researcher Profile: Niranjana Nagarajan
According to Dr. Niranjana Nagarajan, a principal scientist at Celgene, "sheer curiosity" drove her…
READ MORE
Change on the Horizon: The Future of Cancer Treatment
Experts and thought leaders touching every aspect of cancer came together for "Future Shapers: A New…
READ MORE
Researcher Profile: Christina Trout
Christina works in the Epigenetic Department at Celgene as a research scientist, exploring a number…
READ MORE
Advancing Patient Care: How Genomics is Transforming Modern Medicine
At a recent event held by The Atlantic, scientists and researchers joined others in the biopharmaceu…
READ MORE
The Future of Genomics in Disease Treatment and Patient Care
Experts come together for a dialogue focused on the future of genomics, and specifically how genetic…
READ MORE
Researcher Profile: Anita Gandhi
Dr. Anita Gandhi has worked at Celgene since 2002. In her current role, Dr. Gandhi is a translationa…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Jirong Lu
Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.
READ MORE
We Cannot Take Progress for Granted
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE